Patents Examined by Ganapathirama Raghu
-
Patent number: 12252724Abstract: The present invention is related to a novel enzymatic process for production of retinoids via a multi-step process, which process includes the use of heterologous enzymes having activity in a carotene-producing host cell, particularly wherein such process results in high percentage of retinoids, in trans-isoform.Type: GrantFiled: January 30, 2023Date of Patent: March 18, 2025Assignee: DSM IP ASSETS B.V.Inventors: Nathalie Balch, Paul Blomquist, Reed Doten, Peter Houston, Ethan Lam, Jenna McMahon, Joshua Trueheart, Celine Viarouge
-
Patent number: 12252723Abstract: The present invention provides engineered ketoreductase and phosphite dehydrogenase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase and phosphite dehydrogenase enzymes, as well as polynucleotides encoding the engineered ketoreductase and phosphite dehydrogenase enzymes, host cells capable of expressing the engineered ketoreductase and phosphite dehydrogenase enzymes, and methods of using the engineered ketoreductase and phosphite dehydrogenase enzymes to synthesize a chiral catalyst used in the synthesis of antiviral compounds, such as nucleoside inhibitors. The present invention further provides methods of using the engineered enzymes to deracemize a chiral alcohol in a one-pot, multi-enzyme system.Type: GrantFiled: July 14, 2023Date of Patent: March 18, 2025Assignee: Codexis, Inc.Inventors: Jeffrey C. Moore, Jack Liang, Jonathan Penfield, Jovana Nazor, Nikki Dellas, Vesna Mitchell, Da Duan, Iman Farasat, Agustina Rodriguez-Granillo, Grant Murphy, Nicholas Marshall
-
Patent number: 12247208Abstract: The present disclosure concerns recombinant microbial host cell having, in glycolytic conditions, increased glycerol importing activity glycerol as well as, in high osmotic conditions, a decreased NAD-dependent glycerol-3-phosphate dehydrogenase (GPD) activity. The recombinant microbial host cell is particularly useful for the fermentation of sugarcane- or molasses-based medium for the production of ethanol.Type: GrantFiled: May 23, 2018Date of Patent: March 11, 2025Assignee: DANSTAR FERMENT AGInventors: Emily Agnes Stonehouse, John Evan Eck McBride, Kristen M. Deleault, Zachary Losordo, Mitchell Codd
-
Patent number: 12241110Abstract: Described herein are the nucleic acid and the amino acid sequences of a cytochrome P450 capable of oxidizing terpene molecules. Also described herein are methods of oxidizing terpene molecules including contacting the cytochrome P450 with the terpene molecule intended to be oxidized. In particular, the method may be carried out in vitro or in vivo to produce oxidized terpene molecules, which may be used in different technical fields such as for example perfumery and flavoring. Also described herein is an expression vector containing the nucleic acid. A non-human host organism or a cell transformed with the nucleic acid is also an object of the disclosure.Type: GrantFiled: January 16, 2019Date of Patent: March 4, 2025Inventors: Michel Schalk, Letizia Rocci, Fabienne Deguerry
-
Patent number: 12241104Abstract: The present invention also provides for a method to deconstruct a biomass: the method comprising: (a) introducing a solvent to a biomass to dissolve at least part of solid biomass in the solvent, wherein the solvent comprises (i) a metal salt, and (ii) an ionic liquid (IL) or deep eutectic solvent (DES), or mixture thereof, to form a solubilized biomass mixture; (b) optionally introducing an enzyme and/or a microbe to the composition such that the enzyme and/or microbe produce a biofuel and/or chemical compound from the solubilized biomass; and, (c) optionally the biofuel and/or chemical compound is separated from the composition.Type: GrantFiled: April 1, 2021Date of Patent: March 4, 2025Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLCInventors: Lalitendu Das, Hemant Choudhary, John M. Gladden, Blake A. Simmons
-
Patent number: 12234493Abstract: The present invention relates to enzyme compositions for high temperature saccharification of cellulosic material and to uses thereof.Type: GrantFiled: June 13, 2023Date of Patent: February 25, 2025Assignee: Novozymes, Inc.Inventors: Brett McBrayer, Elena Vlasenko, Tarana Shaghasi
-
Patent number: 12227742Abstract: The present inventions generally relate to site-specific delivery of nucleic acid modifiers and includes novel DNA-binding proteins and effectors that can be rapidly programmed to make site-specific DNA modifications. The present inventions also provide a synthetic all-in-one genome editor (SAGE) systems comprising designer DNA sequence readers and a set of small molecules that induce double-strand breaks, enhance cellular permeability, inhibit NHEJ and activate HDR, as well as methods of using and delivering such systems.Type: GrantFiled: October 23, 2018Date of Patent: February 18, 2025Assignees: The Broad Institute, Inc., The Brigham and Women's Hospital, Inc.Inventors: Amit Choudhary, Donghyun Lim, Kurt Cox, Soumyashree Ashok Gangopadhyay
-
Patent number: 12215325Abstract: Described herein are microorganisms, in particular yeast, which have been transformed with one or more expression construct(s) for i) the overexpression of the native genes encoding xylulose kinase (XKS1), transaldolase (TAL1), transketolase 1 (TKL1) and transketolase 2 (TKL2) and ii) the expression of a functional heterologous gene encoding a xylose isomerase (XI), where the xylose isomerase (XI) gene is derived from a microorganism selected from the group consisting of T. neapolitana, A. andensis and C. clariflavum. Also described herein are expression constructs, methods for fermenting pentose sugars using the microorganisms and methods for producing such microorganisms.Type: GrantFiled: March 27, 2019Date of Patent: February 4, 2025Assignee: BASF SEInventors: Haowen Xu, Dominik Satory, Christopher Jackson
-
Patent number: 12215367Abstract: Disclosed are peptides exhibiting betagalactosidase enzyme activity as well as dairy products comprising them and related methods for reducing the lactose content in compositions, such as dairy products.Type: GrantFiled: November 14, 2022Date of Patent: February 4, 2025Assignee: Kerry Group Services International LtdInventors: Hans Raj, Pernille Smith, Thomas Eckhardt, Vojislav Vojinovic, Charlotte Elisabeth Grüner Schöller, Johannes Maarten van den Brink
-
Patent number: 12215366Abstract: Disclosed herein are CRISPR/Cas9-based gene activation systems that include a fusion protein of a Cas9 protein and a protein having histone acetyltransferase activity, and methods of using said systems.Type: GrantFiled: September 10, 2021Date of Patent: February 4, 2025Assignee: Duke UniversityInventors: Charles A. Gersbach, Isaac Hilton
-
Patent number: 12202861Abstract: Drug-inducible, tunable, and multiplexable Clustered Regularly Interspaced Short Palindromic Repeats from Prevotella and Francisella 1 (Cpf1)-based activators, and methods of use thereof.Type: GrantFiled: April 20, 2023Date of Patent: January 21, 2025Assignee: The General Hospital CorporationInventors: Y. Esther Tak, Benjamin Kleinstiver, J. Keith Joung
-
Patent number: 12201655Abstract: Methods and compositions comprising hogocidin peptides (SH-lantibiotics), derivatives and variants are provided. Also provided are methods and compositions comprising probiotic compositions utilizing strains of S. hominis and S. epidermidis that produce hogocidin, hogocidin-like peptides, or other inhibitors of skin pathogens. Methods of treatment for microbial skin infections and atopic dermatitis are also provided.Type: GrantFiled: April 1, 2021Date of Patent: January 21, 2025Assignee: The Regents of the University of CaliforniaInventors: Teruaki Nakatsuji, Richard L. Gallo
-
Patent number: 12195392Abstract: Compositions and methods for producing materials for construction and for dust control utilizing enzyme producing cells, an amount of a nitrogen source such as urea, and an amount of calcium such as calcium chloride. Calcium contributes to the formation of calcium carbonate which creates a solid structure, layer or shield. One or more compositions containing components of the invention can be sprayed or otherwise applied to surfaces for erosion control, foundation support, prevention of sink hole formation, prevention of dust formation, or other applications. Ammonia, water and other by-products of the process can be recycled and re-utilized for the same or other purposes including, for example, as fertilizers and energy sources, or independently fermented from selectively cultivated microorganisms.Type: GrantFiled: January 6, 2022Date of Patent: January 14, 2025Assignee: Biomason Inc.Inventors: Ginger K. Dosier, Victoria M. Durham, Thomas A. Hill, J. Michael Dosier, Steven W. McAllister
-
Patent number: 12188073Abstract: The present invention provides for a genetically modified yeast cell comprising at least six or more of the following modifications: increased expression of Mus musculus fatty acid reductase, acetyl-CoA carboxylase, fatty acid synthase 1, fatty acid synthase 2, a mutant of the bottleneck enzyme encoded by ACC1 insensitive to post-transcriptional and post-translational repression, and/or a desaturase encoded by OLE1, and reduced expression of DGA1, HFD1, ADH6, and/or GDH1. The present invention provides a method for constructing the genetically modified yeast cell, and a method for producing a fatty alcohol from the genetically modified yeast cell.Type: GrantFiled: June 21, 2022Date of Patent: January 7, 2025Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Leopold D'Espaux, Jay D. Keasling
-
Patent number: 12188044Abstract: The present invention provides high efficiency targeted and marker-less single or simultaneous multiple integrations using nucleases and a stable plasmid in Kluyveromyces host cells.Type: GrantFiled: May 18, 2023Date of Patent: January 7, 2025Assignee: Amyris, Inc.Inventor: Jessica Walter
-
Patent number: 12190997Abstract: Aspects of the present disclosure relates to genetically altered LysM receptors. In particular, the present disclosure relates to a hydrophobic patch into the LysM2 domain which can increase affinity and/or selectivity for LCOs and by replacement of regions in the LysM1 domain with the corresponding regions of the LysM1 domain from a donor LysM receptor that can alter the affinity and/or selectivity for the oligosaccharide particularly for LCOs and can alter the specificity between LCO when using regions from a high affinity and specificity LCO LysM receptor such as a legume NFR1 receptor. The present disclosure also relates to genetically altering LysM receptors in plants to include a hydrophobic patch or alter the hydrophobic patch and to genetically altering LysM receptors in plants by replacement of regions in the LysM2 domain.Type: GrantFiled: August 13, 2019Date of Patent: January 7, 2025Assignee: Aarhus UniversitetInventors: Kasper Røjkjær Andersen, Kira Gysel, Elena Simona Radutoiu, Zoltan Bozsoki, Lene Heegaard Madsen, Simon Boje Hansen, Jens Stougaard Jensen
-
Patent number: 12187620Abstract: The invention is directed to kits, compositions, tools and methods comprising a cyclic industrial process to form biocement. In particular, the invention is directed to materials and methods for decomposing calcium carbonate into calcium oxide and carbon dioxide at an elevated temperature, reacting calcium oxide with ammonium chloride to form calcium chloride, water, and ammonia gas; and reacting ammonia gas and carbon dioxide at high pressure to form urea and water, which are then utilized to form biocement. This cyclic process can be achieved by combining industrial processes with the resulting product as biocement. The process may involve retention of calcium carbonate currently utilized in the manufacture of Portland Cement.Type: GrantFiled: November 2, 2022Date of Patent: January 7, 2025Assignee: Biomason Inc.Inventors: Ginger K. Dosier, John Michael Dosier, Kent J. Smith
-
Patent number: 12180525Abstract: A method of demethylizing an opioid to a nor-opioid is provided. The method comprises contacting an opioid with at least one enzyme. Contacting the opioid with the at least one enzyme converts the opioid to a nor-opioid. A method of converting a nor-opioid to a nal-opioid is provided. The method comprises contacting a nor-opioid with at least one enzyme. Contacting the nor-opioid with the at least one enzyme converts the nor-opioid to a nal-opioid.Type: GrantFiled: June 22, 2022Date of Patent: December 31, 2024Assignee: Antheia, Inc.Inventors: Christina D. Smolke, Catherine Thodey, Isis Trenchard
-
Patent number: 12180529Abstract: Genetically modified yeast having a heterologous sugar transporter that is capable of transporting a non-glucose sugar such as maltulose, are described. The heterologous sugar transporter can be a protein according to, or that has similarity to, SEQ ID NO: 44. Fermentation methods using enzymatically treated starch where the yeast are able to consume the non-glucose sugars, are also described. The engineered yeast can be useful for producing desired bioproducts such as high ethanol, with low amounts of residual sugars in the medium.Type: GrantFiled: December 16, 2016Date of Patent: December 31, 2024Assignee: CARGILL, INCORPORATEDInventors: Christopher K. Miller, Ana Negrete-Raymond, Brian J. Rush, Amit Vas, Jon Veldhouse
-
Patent number: 12173347Abstract: The purpose of the present invention is to provide a PHA, in particular PHBV, having a molecular weight exceeding 3,610,000 and/or a method for producing such a PHA while controlling the molecular weight thereof. Provided is a copolymer of random copolymerization of 3-hydroxybutanoic acid and 3-hydroxyvaleric acid, having a weight-average molecular weight exceeding 3,610,000.Type: GrantFiled: September 24, 2019Date of Patent: December 24, 2024Assignee: Sumitomo Forestry Co., LTD.Inventors: Kotaro Ino, Kouichi Ohshiman, Tomo Kakitani, Tomotake Morita, Tokuma Fukuoka, Shun Sato, Azusa Saika, Kazunori Ushimaru